COVID-19 and cancer
Norman E. SharplessNorman E. Sharpless is director of the U.S. National Cancer Institute, Bethesda, MD, USA. norman
ABI
Abstract
With the spread of coronavirus disease 2019 (COVID-19), countries and states have instituted lockdowns. These decisions have been difficult and are sometimes described as benefiting the public health at the expense of the economy. Fear of contracting the coronavirus in health care settings has dissuaded people from screening, diagnosis, and treatment for non–COVID-19 diseases. The consequences for cancer outcomes, for example, could be substantial. What can be done to minimize this effect?
Topics
Identifiers
Citations and references
Cited by 10 references
Metrics — AkademScholar · Coming soon